Prev Next


(1) The pharmacy director/pharmacist-in-charge shall provide forapplicable policies and procedures to ensure:

(a) mechanisms for receiving and verifying drug orders from prescribers and evaluating them for safety and therapeutic appropriateness based on patient parameters and dosing guidelines;

(b) appropriate filling and proper labeling of all containers from which drugs are to be dispensed or administered on an inpatient or outpatient basis;

(c) a system for the admixture of parenteral products accomplished within the pharmacy, and verification that the facility's department of nursing willprovideeducation and training of nursing personnel regarding sterile technique, stability and compatibility of parenteral products not mixed within the pharmacy;

(d) appropriate clinical services and monitoring of outcomes, and the development of new areas of pharmaceutical care appropriate for that institution;

(e) a policy by which an offer is made to convey the discharge medication regimen to a patient's pharmacies;

(f) maintaining and distributing a list of emergency drugs, antidotes, and their doses throughout the institution;

(g) pharmacy participation in formulary development;

(h) participation in drug utilization review and monitoring of adverse drug reactionsand development of procedures to avoid problems identified;

(i) evaluation of reported medication errors and development of procedures to prevent those errors;

(j) proper acquisition and secure, temperature-controlledstorage of all prescription drugs;

(k) quality control of sterile and nonsterile pharmaceutical products, including procedures for identifying, removing and destroying outdated products;

(l) pharmacy safety and security;

(m) utilization of registered technicians or technicians in training;

(n) accurate distribution systems and secure,temperature-controlled storage of pharmaceutical products throughout the institution;

(o) unit-dosing of bulk pharmaceuticals, compounding and sterilization of drug products if applicable;

(p) the appropriate use, security and accountability of controlled substances;

(q) staff development and competency evaluation;

(r) maintenance of all required records; and

(s) compliance with all other requirements of the Montana Board of Pharmacy.

History: 37-7-201, MCA; IMP, 37-7-201, 37-7-307, 37-7-308, MCA; NEW, 2002 MAR p. 3605, Eff. 12/27/02.

Home  |   Search  |   About Us  |   Contact Us  |   Help  |   Disclaimer  |   Privacy & Security